Healthcare Utilization and Costs associated with Hereditary Hemorrhagic Telangiectasia Patients in a Large US Claims Database

OBJECTIVE: To assess the health care costs and utilization in patients with hereditary hemorrhagic telangiectasia (HHT) in the United States. PATIENTS AND METHODS: Retrospective analysis of patients with HHT diagnosed between 2007 and 2017 was performed using deidentified administrative claims data...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mayo Clin Proc Innov Qual Outcomes
Päätekijät: Hasan Albitar, Hasan Ahmad, Van Houten, Holly, Sangaralingham, Lindsey R., Knoedler, Meghan, Almodallal, Yahya, Alkurashi, Adham K., De Moraes, Alice Gallo, Cajigas, Hector, DuBrock, Hillary, Warad, Deepti, Demirel, Nadir, Krowka, Michael, Brinjikji, Waleed, Iyer, Vivek N.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2020
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7930864/
https://ncbi.nlm.nih.gov/pubmed/33718784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mayocpiqo.2020.08.010
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia